Side-by-side comparison of AI visibility scores, market position, and capabilities
Nation's largest homebuilder; 89,690 homes FY2024; $36.8B revenue; Express Homes entry-level focus; Forestar vertical land integration; rate buydown strategy sustains demand vs 6%+ mortgages.
D.R. Horton is the nation's largest homebuilder by volume, founded in 1978 by Donald Ray Horton in Fort Worth, Texas and now headquartered in Arlington, Texas, trading on NYSE (DHI). The company delivered approximately 89,690 homes in fiscal year 2024 (ending September 30) and generated $36.8 billion in revenues under CEO Paul Romanowski, who succeeded longtime CEO David Auld in 2024. D.R. Horton operates across 118 markets in 33 states, targeting the broadest range of price points in the industry from entry-level starter homes under the Express Homes brand through core D.R. Horton family homes to luxury properties under Emerald Homes and Freedom Homes age-restricted communities. The company's scale and geographic diversification provide resilience against regional housing market downturns and allow efficient land acquisition across America's fastest-growing metropolitan markets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.